AGL 40.05 Increased By ▲ 0.05 (0.13%)
AIRLINK 127.05 Increased By ▲ 0.01 (0.01%)
BOP 6.57 Decreased By ▼ -0.10 (-1.5%)
CNERGY 4.53 Increased By ▲ 0.02 (0.44%)
DCL 8.44 Decreased By ▼ -0.11 (-1.29%)
DFML 41.59 Increased By ▲ 0.15 (0.36%)
DGKC 86.66 Decreased By ▼ -0.19 (-0.22%)
FCCL 32.20 Decreased By ▼ -0.08 (-0.25%)
FFBL 65.10 Increased By ▲ 0.30 (0.46%)
FFL 10.15 Decreased By ▼ -0.10 (-0.98%)
HUBC 110.49 Increased By ▲ 0.92 (0.84%)
HUMNL 14.69 Increased By ▲ 0.01 (0.07%)
KEL 5.16 Increased By ▲ 0.11 (2.18%)
KOSM 7.21 Decreased By ▼ -0.25 (-3.35%)
MLCF 41.45 Increased By ▲ 0.07 (0.17%)
NBP 59.81 Decreased By ▼ -0.60 (-0.99%)
OGDC 193.79 Increased By ▲ 3.69 (1.94%)
PAEL 28.00 Increased By ▲ 0.17 (0.61%)
PIBTL 7.90 Increased By ▲ 0.07 (0.89%)
PPL 150.06 No Change ▼ 0.00 (0%)
PRL 26.72 Decreased By ▼ -0.16 (-0.6%)
PTC 16.10 Increased By ▲ 0.03 (0.19%)
SEARL 78.00 Decreased By ▼ -8.00 (-9.3%)
TELE 7.38 Decreased By ▼ -0.33 (-4.28%)
TOMCL 35.40 Decreased By ▼ -0.01 (-0.03%)
TPLP 7.86 Decreased By ▼ -0.26 (-3.2%)
TREET 15.90 Decreased By ▼ -0.51 (-3.11%)
TRG 52.75 Decreased By ▼ -0.54 (-1.01%)
UNITY 26.50 Increased By ▲ 0.34 (1.3%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
BR100 9,949 Increased By 65.7 (0.66%)
BR30 30,910 Increased By 309.7 (1.01%)
KSE100 94,021 Increased By 665.8 (0.71%)
KSE30 29,143 Increased By 212 (0.73%)

Drug Regulatory Agency of Pakistan (Cabinet Division), in exercise of the powers conferred by section 12 of the Drugs Act, 1976 (XXXI of 1976), the Federal Government, through a notification, has allowed addition of up to Rs 4 and Rs 10 per bottle of 60ml, 120ml and 450ml respectively in their respective Maximum Retail Prices (MRPs) of liquid cough preparations fixed by the federal government.
Subject to the fulfilment following conditions namely:
(i) valid drug manufacturing license/ drug sale license and drug registration.
(ii) the manufacturers and importers of drugs shall furnish the MRPs of drugs with evidence to the Pricing Section before implementation and stickers are not allowed.
(iii) print the retail price on the label in the manner prescribed by the Drugs (Labelling and Packing) Rules; and (iv) raw material used for drugs manufacturing shall be purchased from established source per official pharmacopoeia under section 3 of Drugs Act 1976.-PR

Copyright Business Recorder, 2012

Comments

Comments are closed.